Amgen Inc. - Company & Market Research Reports

Home /
Companies /
Amgen Inc.

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 332
Immune Disorders Drugs 209
Biopharmaceuticals 178
Musculoskeletal Disorders Drugs 126
Genomics 114
Cardiovascular Drugs 106
Biotechnology 83
Pharmaceuticals 81
Drug Discovery 78
Endocrine and Metabolic Disorders Drugs 77
Biosimilars and Biosuperiors 72
Allergy and Immunology 67
Infusions and Injectables 63
Leukemia Drugs 62
Hematological Drugs 60
Oncology 52
Clinical Trials 51
Dermatological Drugs 50
Central Nervous System Drugs 49
Liver and Kidney Disorders Drugs 45
Women's Health 44
Needles and Syringes 40
Drug Delivery 38
Psoriasis Drugs 37
Diagnostics 36
Skin Cancer Drugs 35
Hematology 29
Brain Cancer Drugs 28
Proteomics 27
Enzymes 27
Gastrointestinal Drugs 27
Lung Cancer Drugs 26
Colon Cancer Drugs 26
Analgesics 24
Immunosuppressive Drugs 24
Infectious Diseases Drugs 23
Lymphoma Drugs 22
Pharmaceutical Manufacturing 19
Drugs by Therapeutic Area 18
Dermatology 18
Optical 17
Therapeutic Area 16
Healthcare Services 15
Respiratory Drugs 15
Urology and Nephrology 14
Kidney Cancer Drugs 14
Optical Disorders Drugs 13
Pancreatic Cancer Drugs 12
Nanomedicine 11
Generic Drugs 10
Breast Cancer Drugs 10
Prostate Cancer Drugs 10
Ovarian Cancer Drugs 10
Cervical Cancer Drugs 10
Cardiology 10
Sexual and Reproductive Health Drugs 10
E-Healthcare 9
Liver Cancer Drugs 8
Cancer Vaccines 8
Other Healthcare Facilities 8
Gastroenterology 8
Pulmonary Medicine 7
In Vitro Diagnostics 7
Biomarkers 7
Anti-Obesity Drugs 7
Neurology 6
Diabetes Drugs 6
Biomaterials 6
Vaccines 6
Mental Disorders Drugs 6
Animal Pharmaceuticals 5
Medical Devices 5
Molecular Diagnostics 5
Over the Counter (OTC) Drugs 5
Pediatrics 5
Asthma Drugs 5
Company Reports 4
Pharmaceutical Intermediates 4
Surgical Procedures 4
Thyroid Cancer Drugs 4
Alzheimer's Disease Drugs 4
Managed Care 3
Stem Cells 3
Endocrinology 3
Addiction Disorders Drugs 2
Bladder Cancer Drugs 2
Cardiovascular Devices 2
Infectious Disease Testing 2
Inhalers and Nebulisers 2
Mental Health 2
Uterine Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Antibiotics 2
Acne Drugs 2
Urological Disorders Drugs 2
Schizophrenia Drugs 2
Hepatology 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Orthopedic Devices 1
Cholesterol Testing 1
Cough and Cold Drugs 1
Healthcare 1
Radiography 1
Transdermal and Transmucosal Drug Delivery 1
Blood Banking 1
Hospital Management 1
Respiratory Devices 1
Clinical Therapies 1
Clinical Skills 1
Palliative Care 1
Anatomy 1
Maternal and Neonatal Care 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



284 reviews

2,085 Results (Page 79 of 105)
- Relevance
  Sort by

U.S. Gene Therapy Market - Industry Outlook & Forecast 2022-2027

 Report
March 2022
208 Pages
United States

From

€3217EUR$3,500USD£2,742GBP

Precision Medicine: Global Markets

 Report
August 2023
65 Pages
Global

From

€4274EUR$4,650USD£3,643GBP

Combination Antibody Therapy Market - Global Forecast 2026-2032

 Report
September 2026
194 Pages
Global

From

€3259EUR$3,545USD£2,777GBP

€3621EUR$3,939USD£3,086GBP

Antineoplastic Agents Market - Global Forecast 2026-2032

 Report
September 2026
185 Pages
Global

From

€3259EUR$3,545USD£2,777GBP

€3621EUR$3,939USD£3,086GBP

NDDS in Cancer Therapy Market - Global Forecast 2026-2032

 Report
September 2026
183 Pages
Global

From

€3259EUR$3,545USD£2,777GBP

€3621EUR$3,939USD£3,086GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Immunotherapy Drugs Market - Global Forecast 2026-2032

 Report
September 2026
181 Pages
Global

From

€3259EUR$3,545USD£2,777GBP

€3621EUR$3,939USD£3,086GBP

Subcutaneous Drug Delivery Devices Market Analysis & Forecast to 2024-2034: Market By Product; By Usability; By Disease Indication; By Distribution Channel; and By Region

 Report
March 2024
200 Pages
Global

From

€3815EUR$4,150USD£3,251GBP

Chronic Kidney Disease (CKD) Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
118 Pages
Global

From

€4137EUR$4,500USD£3,526GBP

Global Stem Cells Market: Focus on Clinical Therapies, 2020 - 2030

 Report
January 2020
508 Pages
Global

From

€4503EUR$4,899USD£3,838GBP

Catalepsy Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,518GBP

Multiple Sclerosis Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,518GBP

Crohn's Disease - Pipeline Insight, 2025

 Clinical Trials
April 2025
240 Pages
Global

From

€2758EUR$3,000USD£2,350GBP

Rhinosinusitis - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1838EUR$2,000USD£1,567GBP

Global Cancer Immunotherapy Market Analysis & Forecast to 2025

 Report
November 2020
450 Pages
Global

From

€4504EUR$4,900USD£3,839GBP

Short-read Sequencing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables), By Workflow, By Application, By End-Use, By Region, And Segment Forecasts, 2023 - 2030

 Report
March 2023
180 Pages
Global

From

€5469EUR$5,950USD£4,662GBP

Neurofibromatosis Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,518GBP

Antibody Fragments Market - Global Forecast 2026-2032

 Report
September 2026
188 Pages
Global

From

€3259EUR$3,545USD£2,777GBP

€3621EUR$3,939USD£3,086GBP

Cancer Drugs Market - Global Forecast 2026-2032

 Report
September 2026
191 Pages
Global

From

€3259EUR$3,545USD£2,777GBP

€3621EUR$3,939USD£3,086GBP

Head & Neck Cancer Drugs Market - Global Forecast 2026-2032

 Report
September 2026
189 Pages
Global

From

€3259EUR$3,545USD£2,777GBP

€3621EUR$3,939USD£3,086GBP

GLP-1 Receptor Agonist Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,518GBP

2,085 Results (Page 79 of 105)
- 1
- 77
- 78
- 79
- 80
- 81

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.